B.R.A.I.N. Biotechnology Research And Information Network AG (DE000520)

BRIEF

published on 12/12/2024 at 09:05, 9 days 4 hours ago

BRAIN Biotech AG Refocuses on Profitable Growth

Profitable Growth Financial Forecast Strategic Initiatives BRAIN Biotech Enzyme Business
PRESS RELEASE

published on 12/12/2024 at 09:00, 9 days 4 hours ago

BRAIN Biotech AG Sharpens Focus on Profitable Growth
BRAIN Biotech AG sharpens focus on profitable growth by creating new growth segment BRAINBiocatalysts. Targets include EUR 100 million revenues, 15% adjusted EBITDA margin, and high R&D ratio

Profitable Growth Financial Forecast BRAIN Biotech AG Enzyme Business BRAINBiocatalysts
BRIEF

published on 10/31/2024 at 19:25, 1 month 20 days ago

Exclusive Licensing Agreement Boosts BRAIN Biotech's Pharma Ventures

BRAIN Biotech CRISPR-Cas Technology G-dase E® Pharma Licensing Akribion Therapeutics
PRESS RELEASE

published on 10/31/2024 at 19:20, 1 month 20 days ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 1 month 20 days ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
PRESS RELEASE

published on 10/31/2024 at 19:11, 1 month 20 days ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 2 months 17 days ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 2 months 17 days ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 3 months ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes
BRIEF

published on 09/20/2024 at 19:52, 3 months ago

BRAIN Biotech AG Secures Royalty Monetization Deal Worth Up to EUR 128.88 Million

BRAIN Biotech Royalty Monetization Deucrictibant Royalty Pharma Hereditary Angioedema

1 2 ... 5

Published on 12/21/2024 at 01:30, 12 hours 3 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 3 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 28 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 33 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 3 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 42 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 48 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 22 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 37 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 33 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 15 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 33 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 38 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 33 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News